Implementation of nanotechnology in healthcare: immense challenges and opportunities

Ayush Chandra Mishra
Ratnesh Chaubey
Shobhit Prakash Srivastava


Healthcare, being a fundamental human right, has frequently been the focus of technological innovation. Technological advancements have aided in the delivery of high-quality, on-time, acceptable, and cheap healthcare. A new generation of nanostructures has emerged as a result of advances in nanoscience. Each one has its own set of characteristics that account for its amazing applicability. Nanotechnology has had a continual impact on healthcare since its birth and has had a significant impact on its evolution, contributing to better outcomes. Nanotechnology's application in healthcare is pushing the life sciences sector to new heights. Nanotechnology has the potential to improve many parts of medical care, including diagnostics, disease monitoring, surgical equipment, regenerative medicine, vaccine development, and medication delivery, thanks to its capacity to alter matter at the atomic level. Advanced research tools that can be used for drug discovery are also opening doors to better treatment options for various diseases. Nanotechnology has made strides toward omnipresence over the previous two decades, and this trend has been hastened by substantial studies in several healthcare industries. Nanomedicine is the application of nanotechnology and its associated nanocarriers/nanosystems to medicine, a field that has yielded several improvements in illness prevention, diagnosis, and therapy. In comparison to traditional nanosystems, some nanosystems have been discovered to be better prospects for theragnostic applications. This review paper will discuss medically significant nanosystems, as well as their applications and limits in fields like gene therapy, targeted medication delivery, and cancer and genetic disease treatment.

This article is a part of Special Issue "Advances in the field of Nanomedicine"

DOI: 10.55006/biolsciences.2022.2303
Published: 29-07-2022

How to Cite
Mishra, A. C., Chaubey, R. ., & Srivastava, S. P. . (2022). Implementation of nanotechnology in healthcare: immense challenges and opportunities. Biological Sciences, 2(3), 251–261.


Zdrojewicz Z, Waracki M, Bugaj B, Pypno D, Cabała K. Medical applications of nanotechnology. Advances in Hygiene & Experimental Medicine/Postepy Higieny i Medycyny Doswiadczalnej. 2015 Jan 1;69.

Owen A, Dufès C, Moscatelli D, Mayes E, Lovell JF, Katti KV, Sokolov K, Mazza M, Fontaine O, Rannard S, Stone V. The application of nanotechnology in medicine: treatment and diagnostics. Nanomedicine. 2014 Jul;9(9):1291-4.

Sindhwani S, Chan WC. Nanotechnology for modern medicine: next step towards clinical translation. Journal of Internal Medicine. 2021 Sep;290(3):486-98.

Agarwal H, Kumar SV, Rajeshkumar S. A review on green synthesis of zinc oxide nanoparticles–An eco-friendly approach. Resource-Efficient Technologies. 2017 Dec 1;3(4):406-13.

Baker JR, Brent Jr BW, Thomas TP. Nanotechnology in Clinical and Translational Research. InClinical and Translational Science 2009 Jan 1 (pp. 123-135). Academic Press.

Sahu AN. Nanotechnology in herbal medicines and cosmetics. International Journal of Research in Ayurveda and Pharmacy (IJRAP). 2013;4(3):472-4.

Subramani K, Ahmed W, Pachauri P. Titanium nanotubes as carriers of osteogenic growth factors and antibacterial drugs for applications in dental implantology. InEmerging Nanotechnologies in Dentistry 2018 Jan 1 (pp. 125-136). William Andrew Publishing.

Khan AU, Khan M, Cho MH, Khan MM. Selected nanotechnologies and nanostructures for drug delivery, nanomedicine and cure. Bioprocess and biosystems engineering. 2020 Aug;43(8):1339-57.

Fakruddin M, Hossain Z, Afroz H. Prospects and applications of nanobiotechnology: a medical perspective. Journal of nanobiotechnology. 2012 Dec;10(1):1-8.

Rizvi SA, Saleh AM. Applications of nanoparticle systems in drug delivery technology. Saudi pharmaceutical journal. 2018 Jan 1;26(1):64-70.

Ali S, Khan I, Khan SA, Sohail M, Ahmed R, ur Rehman A, Ansari MS, Morsy MA. Electrocatalytic performance of Ni@ Pt core–shell nanoparticles supported on carbon nanotubes for methanol oxidation reaction. Journal of Electroanalytical Chemistry. 2017 Jun 15;795:17-25.

Zhao B, Hu H, Mandal SK, Haddon RC. A bone mimic based on the self-assembly ofhydroxyapatite on chemically functionalized single-walled carbon nanotubes. Chemistry of Materials. 2005 Jun 14;17(12):3235-41.

Ojha S, Kumar B. A review on nanotechnology based innovations in diagnosis and treatment of multiple sclerosis. Journal of Cellular Immunotherapy. 2018 Dec 1;4(2):56-64.

Tripathi N, Pavelyev V, Islam SS. Synthesis of carbon nanotubes using green plant extract as catalyst: unconventional concept and its realization. Applied Nanoscience. 2017 Nov;7(8):557-66.

Mittal P, Saharan A, Verma R, Altalbawy F, Alfaidi MA, Batiha GE, Akter W, Gautam RK, Uddin M, Rahman M. Dendrimers: a new race of pharmaceutical nanocarriers. BioMed Research International. 2021 Feb 15;2021.

Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S. Advances and challenges of liposome assisted drug delivery. Frontiers in pharmacology. 2015 Dec 1;6:286.

Genç R, Clergeaud G, Ortiz M, O’sullivan CK. Green synthesis of gold nanoparticles using glycerol-incorporated nanosized liposomes. Langmuir. 2011 Sep 6;27(17):10894-900.

Zhao MX, Zhu BJ. The research and applications of quantum dots as nano-carriers for targeted drug delivery and cancer therapy. Nanoscale Research Letters. 2016 Dec;11(1):1-9.

Gharbavi M, Amani J, Kheiri-Manjili H, Danafar H, Sharafi A. Niosome: a promising nanocarrier for natural drug delivery through blood-brain barrier. Advances in pharmacological sciences. 2018 Dec 11;2018.

Yang D, Yang F, Hu J, Long J, Wang C, Fu D, Ni Q. Hydrophilic multi-walled carbon nanotubes decorated with magnetite nanoparticles as lymphatic targeted drug delivery vehicles. Chemical Communications. 2009(29):4447-9.

Anjum S, Ishaque S, Fatima H, Farooq W, Hano C, Abbasi BH, Anjum I. Emerging applications of nanotechnology in healthcare systems: Grand challenges and perspectives. Pharmaceuticals. 2021 Jul 21;14(8):707.

Kamau SW, Hassa PO, Steitz B, Petri-Fink A, Hofmann H, Hofmann-Amtenbrink M, Von Rechenberg B, Hottiger MO. Enhancement of the efficiency of non-viral gene delivery by application of pulsed magnetic field. Nucleic Acids Research. 2006 Jan 1;34(5):e40-.

Ojha S, Kumar B, Chadha H. Neuroprotective potential of dimethyl fumarate-loaded polymeric Nanoparticles against multiple sclerosis. Indian Journal of Pharmaceutical Sciences. 2019 May 27;81(3):496-502.24. Shubayev VI, Pisanic II TR, Jin S. Magnetic nanoparticles for theragnostics. Advanced drug delivery reviews. 2009 Jun 21;61(6):467-77.

Kaul G, Amiji M. Tumor-targeted gene delivery using poly (ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies. Pharmaceutical research. 2005 Jun;22(6):951-61.

Ojha S. In vitro and In vivo neuroprotective study of solid lipid nanoparticles loaded with dimethyl fumarate. Asian Journal of Pharmaceutics (AJP). 2018 May 13;12(01).

Zheng G, Chen J, Li H, Glickson JD. Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proceedings of the National Academy of Sciences. 2005 Dec 6;102(49):17757-62.

Martinez-Boubeta C, Balcells L, Cristòfol R, Sanfeliu C, Rodríguez E, Weissleder R, Lope-Piedrafita S, Simeonidis K, Angelakeris M, Sandiumenge F, Calleja A. Self-assembled multifunctional Fe/MgO nanospheres for magnetic resonance imaging and hyperthermia. Nanomedicine: Nanotechnology, Biology and Medicine. 2010 Apr 1;6(2):362-70.

Cheng Y, Wang J, Rao T, He X, Xu T. Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery. Frontiers in Bioscience-Landmark. 2008 Jan 1;13(4):1447-71.

Rommasi F, Esfandiari N. Liposomal nanomedicine: applications for drug delivery in cancer therapy. Nanoscale Research Letters. 2021 Dec;16(1):1-20.

Smolin G, Okumoto M, Feiler S, Condon D. Idoxuridine-liposome therapy for herpes simplex keratitis. American journal of ophthalmology. 1981 Feb 1;91(2):220-5.

Wittgen BP, Kunst PW, Van Der Born K, Van Wijk AW, Perkins W, Pilkiewicz FG, Perez-Soler R, Nicholson S, Peters GJ, Postmus PE. Phase I study of aerosolized SLIT cisplatin in the treatment of patients with carcinoma of the lung. Clinical cancer research. 2007 Apr 15;13(8):2414-21.

Chen M, Zhang J, Yu S, Wang S, Zhang Z, Chen J, Xiao J, Wang Y. Anti-lung-cancer activity and liposome-based delivery systems of β-elemene. Evidence-Based Complementary and Alternative Medicine. 2012 Jan 1;2012.

Pardakhty A, Varshosaz J, Rouholamini A. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. International

journal of pharmaceutics. 2007 Jan 10;328(2):130-41.

Terzano C, Allegra L, Alhaique F, Marianecci C, Carafa M. Non-phospholipid vesicles for pulmonary glucocorticoid delivery. European Journal of Pharmaceutics and Biopharmaceutics. 2005 Jan 1;59(1):57-62

Brewer JM, Alexander J. The adjuvant activity of non-ionic surfactant vesicles (niosomes) on the BALB/c humoral response to bovine serum albumin. Immunology. 1992 Apr;75(4):570.

Sharma S, Rabbani SA, Agarwal T, Baboota S, Pottoo FH, Kadian R. Nanotechnology driven approaches for the management of Parkinson’s disease: Current status and future perspectives. Current Drug Metabolism. 2021 Apr 1;22(4):287-98.

Ruzycka-Ayoush M, Kowalik P, Kowalczyk A, Bujak P, Nowicka AM, Wojewodzka M, Kruszewski M, Grudzinski IP. Quantum dots as targeted doxorubicin drug delivery nanosystems in human lung cancer cells. Cancer Nanotechnology. 2021 Dec;12(1):1-27.

Bwatanglang IB, Mohammad F, Yusof NA, Abdullah J, Alitheen NB, Hussein MZ, Abu N, Mohammed NE, Nordin N, Zamberi NR, Yeap SK. In vivo tumor targeting and anti-tumor effects of 5-fluororacil loaded, folic acid targeted quantum dot system. Journal of colloid and interface science. 2016 Oct 15;480:146-58.

Ojha SM, Kumar BA. Formulation and optimization of chitosan nanoparticles of dimethyl fumarate using box-behnken design. Int J Appl Pharm. 2016;8(4):10-7.

Landesman-Milo D, Goldsmith M, Ben-Arye SL, Witenberg B, Brown E, Leibovitch S, Azriel S, Tabak S, Morad V, Peer D. Hyaluronan grafted lipid-based nanoparticles as RNAi carriers for cancer cells. Cancer letters. 2013 Jul 1;334(2):221-7.

Gorain B, Choudhury H, Kundu A, Sarkar L, Karmakar S, Jaisankar P, Pal TK. Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats. Colloids and Surfaces B: Biointerfaces. 2014 Mar 1;115:286-94.

Ojha S, Kumar B. Preparation and statistical modeling of solid lipid nanoparticles of dimethyl fumarate for better management of multiple sclerosis. Advanced pharmaceutical bulletin. 2018 Jun;8(2):225.

Quinteros, D.A., Tártara, L.I., Palma, S.D., Manzo, R.H. and Allemandi, D.A., 2014. Ocular delivery of flurbiprofen based onEudragit® E-flurbiprofen complex dispersed in aqueous solution: preparation, characterization, in vitro corneal penetration, and ocular irritation. Journal of Pharmaceutical Sciences, 103(12), pp.3859-3868.

Pignatello R, Bucolo C, Spedalieri G, Maltese A, Puglisi G. Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials. 2002 Aug 1;23(15):3247-55.

Sengupta S, Eavarone D, Capila I, Zhao G, Watson N, Kiziltepe T, Sasisekharan R. Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system. Nature. 2005 Jul;436(7050):568-72.

Chi X, Huang D, Zhao Z, Zhou Z, Yin Z, Gao J. Nanoprobes for in vitro diagnostics of cancer and infectious diseases. Biomaterials. 2012 Jan 1;33(1):189-206.

Ngowi EE, Wang YZ, Qian L, Helmy YA, Anyomi B, Li T, Zheng M, Jiang ES, Duan SF, Wei JS, Wu DD. The application of nanotechnology for the diagnosis and treatment of brain diseases and disorders. Frontiers in Bioengineering and Biotechnology. 2021 Mar 2;9:629832.

Srikanth M, Kessler JA. Nanotechnology—novel therapeutics for CNS disorders. Nature reviews neurology. 2012 Jun;8(6):307-18.

Huang X, Ma Y, Li Y, Han F, Lin W. Targeted drug delivery systems for kidney diseases. Frontiers in Bioengineering and Biotechnology. 2021:409.

Manil L, Davin JC, Duchenne C, Kubiak C, Foidart J, Couvreur P, Mahieu P. Uptake of nanoparticles by rat glomerular mesangial cells in vivo and in vitro. Pharmaceutical research. 1994 Aug;11(8):1160-5.